American CryoStem Corporation reported earnings results for the third quarter and nine months ended June 30, 2022. For the third quarter, the company reported revenue was USD 0.042599 million compared to USD 0.1298 million a year ago. Net loss was USD 0.401689 million compared to USD 0.46647 million a year ago. Basic loss per share from continuing operations was USD 0.009 compared to USD 0.008 a year ago. Diluted loss per share from continuing operations was USD 0.009 compared to USD 0.008 a year ago.
For the nine months, revenue was USD 0.135719 million compared to USD 0.383335 million a year ago. Net loss was USD 1.75 million compared to USD 0.817233 million a year ago. Basic loss per share from continuing operations was USD 0.037 compared to USD 0.014 a year ago. Diluted loss per share from continuing operations was USD 0.037 compared to USD 0.014 a year ago.